Phaarmasia Ltd (523620) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 523620 | NSE: | Pharmaceuticals & Drugs | Small Cap

Phaarmasia Share Price

79.90 3.80 4.99%
as on 05-Dec'25 12:17

Phaarmasia Ltd (523620) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 523620 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Phaarmasia

Based on:

M-Cap below 100cr DeciZen not available

Phaarmasia stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
66.61
Market Cap:
52 Cr.
52-wk low:
23.6
52-wk high:
76.1

Is Phaarmasia Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Phaarmasia: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Phaarmasia Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 3.4%3.6%9.3%10.4%11.1%5.2%-18%-19.2%-8%-30.1%-
Value Creation
Index
-0.8-0.7-0.3-0.3-0.2-0.6-2.3-2.4-1.6-3.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 21.614.420.224.224.519.917.227.530.624.434
Sales YoY Gr.--33.6%40.5%19.9%1%-18.6%-13.5%59.6%11.3%-20.3%-
Adj EPS 0.10.20.81.10.80.5-2.3-1.8-0.8-2.31.1
YoY Gr.-300%250%26.2%-25.5%-41.8%-593.5%NANANA-
BVPS (₹) 11.210.911.412.613.413.811.59.68.96.69.5
Adj Net
Profit
00.20.60.70.50.3-1.6-1.3-0.5-1.61
Cash Flow from Ops. 0.3-0.10.90.10.10.3-0.20.70.1-0-
Debt/CF from Ops. 0.1-0.80.33.31.10.2-0.2000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 1.3%-0.1%12.3%-20.3%
Adj EPS -250.2%-224.2%NANA
BVPS-5.7%-13.3%-16.9%-25.8%
Share Price 12.1% 27.7% 35.5% 65%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.31.44.85.84.12.3-12-11-4.9-16.714.2
Op. Profit
Mgn %
10.92.433.4-0.3-10.1-5.6-2.7-8.30.9
Net Profit
Mgn %
0.21.12.832.21.6-9-4.6-1.7-6.52.3
Debt to
Equity
00000000000
Working Cap
Days
638811319129326217715419820468
Cash Conv.
Cycle
-44-53-39-47-1426-15-34-51-29

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Phaarmasia Ltd.

Standalone Consolidated
TTM EPS (₹) 1.1 -
TTM Sales (₹ Cr.) 33.6 -
BVPS (₹.) 9.5 -
Reserves (₹ Cr.) - -
P/BV 7.99 -
PE 66.61 -
From the Market
52 Week Low / High (₹) 23.60 / 76.10
All Time Low / High (₹) 0.05 / 420.00
Market Cap (₹ Cr.) 52
Equity (₹ Cr.) 6.8
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Phaarmasia:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Phaarmasia - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Phaarmasia

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales21.6114.3620.1824.2024.4519.9017.2227.4930.5924.37
Operating Expenses 21.3914.2319.6923.4723.6319.9618.9529.0331.4126.38
Manufacturing Costs5.586.278.938.108.365.285.8411.0810.038.79
Material Costs4.114.277.2511.1612.4212.2110.5514.8818.2314.37
Employee Cost 1.451.421.661.551.401.271.171.411.531.68
Other Costs 10.262.271.842.651.461.201.401.661.631.54
Operating Profit 0.220.130.490.730.82-0.06-1.74-1.54-0.82-2.01
Operating Profit Margin (%) 1.0%0.9%2.4%3.0%3.3%-0.3%-10.1%-5.6%-2.7%-8.3%
Other Income 0.530.580.690.600.580.890.470.520.660.75
Interest 0.010.010.040.040.040.0100.040.040.02
Depreciation 0.500.440.470.460.400.340.290.360.340.32
Exceptional Items 0000000000
Profit Before Tax 0.240.270.680.830.960.48-1.56-1.43-0.55-1.60
Tax 0.200.100.110.050.420.17-0.02-0.17-0.03-0.01
Profit After Tax 0.040.160.570.780.540.31-1.55-1.26-0.52-1.59
PAT Margin (%) 0.2%1.1%2.8%3.2%2.2%1.6%-9.0%-4.6%-1.7%-6.5%
Adjusted EPS (₹)0.10.20.81.10.80.5-2.3-1.8-0.8-2.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 11.8711.6612.0212.8213.4113.6512.0610.8110.308.74
Share Capital 6.836.836.836.836.836.836.836.836.836.83
Reserves 5.044.835.205.996.586.835.233.983.471.91
Minority Interest0000000000
Debt00.050.120.160.080.050.030.0100
Long Term Debt00.050.1200.030.020.010.0100
Short Term Debt0000.160.050.030.02000
Trade Payables3.495.407.4117.8918.266.658.1316.5420.0811.96
Others Liabilities 3.282.442.372.381.851.561.021.041.060.89
Total Liabilities 18.6319.5421.9233.2633.6021.9121.2428.4031.4321.59

Fixed Assets

Gross Block34.5014.1815.0815.1215.1215.1215.1215.4015.5315.70
Accumulated Depreciation20.380.440.911.331.722.072.362.613.053.37
Net Fixed Assets 14.1113.7414.1813.8013.4013.0612.7612.7912.4812.32
CWIP 0000000000
Investments 0000000000
Inventories0.191.031.295.976.082.634.246.368.503.06
Trade Receivables2.913.563.7911.7612.324.273.197.518.053.11
Cash Equivalents 0.440.150.190.190.150.380.220.690.630.36
Others Assets 0.981.052.471.541.641.570.821.061.782.74
Total Assets 18.6319.5421.9233.2633.6021.9121.2428.4031.4321.59

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.28-0.080.880.060.080.25-0.180.650.11-0
PBT 0.240.270.680.830.960.48-1.56-1.43-0.55-1.60
Adjustment 0.510.430.260.480.470.250.240.380.350.28
Changes in Working Capital -0.25-0.680.07-1.09-1.09-0.241.321.710.31.32
Tax Paid -0.22-0.11-0.13-0.17-0.26-0.24-0.17000
Cash Flow From Investing Activity -0.28-0.18-0.92-0.10-000.01-0.01-0-0.12
Capex -0.28-0.07-0.90-0.08000-0.03-0.03-0.17
Net Investments 0000000000
Others 0-0.11-0.02-0.02-000.010.010.030.05
Cash Flow From Financing Activity 0.16-0.020.080.04-0.11-0.020-0.16-0.16-0.15
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.05-0.020.080.04-0.11-0.020-0.02-0.010
Interest Paid -0.01000000-0.02-0.04-0.02
Dividend Paid 0000000000
Others 0.13000000-0.12-0.11-0.13
Net Cash Flow 0.17-0.290.04-0-0.030.23-0.170.48-0.06-0.27

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.552.167.549.516.083.36-17.96-17.5-8.21-30.12
ROCE (%)3.353.639.3210.3511.075.24-18-19.24-7.95-30.07
Asset Turnover Ratio1.141.051.030.930.730.720.81.111.020.92
PAT to CFO Conversion(x)7-0.51.540.080.150.81N/AN/AN/AN/A
Working Capital Days
Receivable Days38596311118015279719384
Inventory Days13112052908073708987
Payable Days287379322414531372256303367407

Phaarmasia Ltd Stock News

Phaarmasia Ltd FAQs

The current trading price of Phaarmasia on 05-Dec-2025 12:17 is ₹79.90.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Phaarmasia stood at ₹51.95.
The latest P/E ratio of Phaarmasia as of 04-Dec-2025 is 66.61.
The latest P/B ratio of Phaarmasia as of 04-Dec-2025 is 7.99.
The 52-week high of Phaarmasia is ₹76.10 and the 52-week low is ₹23.60.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Phaarmasia is ₹33.58 ( Cr.) .

About Phaarmasia Ltd

The company was incorporated on  February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

The company was established for  carrying on the business as manufacturers, buyers, sellers, importers, exporters, distributors, agents and or otherwise deal as wholesalers, or retailers in drugs, medicines, pharmaceuticals, chemicals and other intermediates, dyes pigments, paints, rubber chemicals, phyto chemicals, hormones, agro-chemicals, veterinary and poultry products, food and nutritional products, house-hold remedies, biological and herbal products.

Phaarmasia’s registered office is located at 16,Phase III, I.D.A Jeedimetla, Hyderabad, Andhra Pradesh 500 055, India.

The company had restructured its Paid up Share Capital account of 91,34,800 Equity Shares of Rs 10 each fully paid up as on 31st, March,2005 by reducing / debiting the amount of Rs 730.78 lakhs for setting off the Accumulated Losses of the Company and has further allotted 50,00,000 Equity Shares of Rs 10each to promoters and Associates for Rs 250 lakhs and balance to Unsecured Creditors as approved in the above Scheme of Arrangement.

Product range of the company includes:

Phaarmasia’s product range includes amexine, angicare, flamfort, nasorel, flemkof, ginadox, medix and ziron. Its amexine is an antibiotic, which is used for upper respiratory tract infections, mucolytic and expectorant.

Company also provides nasorel PR, which is a therapeutic category that comes under antihistamine and sympathomimetic.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×